Consistency matters.
Continue to choose CARBAGLU.

CARBAGLU is the first FDA-approved medication indicated for adult and pediatric patients as:

  • Adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to N-acetylgutamate synthase (NAGS) deficiency.
  • Maintenance therapy for the treatment of chronic hyperammonemia due to N-acetylgutamate synthase (NAGS) deficiency.
  • Adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to propionic acidemia (PA) or methylmalonic acidemia (MMA).
X
X
X